BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 2010;198:209-22. [PMID: 19555382 DOI: 10.1111/j.1748-1716.2009.02012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sagawa Y, Sato M, Sakai N, Chikahisa S, Chiba S, Maruyama T, Yamamoto J, Nishino S. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Neuropharmacology 2016;110:268-76. [PMID: 27474349 DOI: 10.1016/j.neuropharm.2016.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 La Torre ME, Villano I, Monda M, Messina A, Cibelli G, Valenzano A, Pisanelli D, Panaro MA, Tartaglia N, Ambrosi A, Carotenuto M, Monda V, Messina G, Porro C. Role of Vitamin E and the Orexin System in Neuroprotection. Brain Sci 2021;11:1098. [PMID: 34439717 DOI: 10.3390/brainsci11081098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nishino S, Sagawa Y. The Neurochemistry of Awakening. Science of Awakening. Elsevier; 2010. pp. 229-55. [DOI: 10.1016/s0074-7742(10)93010-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Jara O. C, Popp R, Zulley J, Hajak G, Geisler P. Determinants of Depressive Symptoms in Narcoleptic Patients With and Without Cataplexy. Journal of Nervous & Mental Disease 2011;199:329-34. [DOI: 10.1097/nmd.0b013e3182174fd3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Darlix A, Mathey G, Monin ML, Sauvée M, Braun M, Schaff JL, Debouverie M. [Hypothalamic involvement in multiple sclerosis]. Rev Neurol (Paris) 2012;168:434-43. [PMID: 22136879 DOI: 10.1016/j.neurol.2011.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 McClung CA. How might circadian rhythms control mood? Let me count the ways... Biol Psychiatry 2013;74:242-9. [PMID: 23558300 DOI: 10.1016/j.biopsych.2013.02.019] [Cited by in Crossref: 264] [Cited by in F6Publishing: 247] [Article Influence: 29.3] [Reference Citation Analysis]
7 Masoudi S, Ploen D, Kunz K, Hildt E. The adjuvant component α-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy. Vaccine 2014;32:2980-8. [PMID: 24721530 DOI: 10.1016/j.vaccine.2014.03.085] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
8 Durairaja A, Fendt M. Orexin deficiency modulates cognitive flexibility in a sex-dependent manner. Genes Brain Behav 2021;20:e12707. [PMID: 33070452 DOI: 10.1111/gbb.12707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dauvilliers Y, Lopez R, Ohayon M, Bayard S. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med 2013;11:78. [PMID: 23514569 DOI: 10.1186/1741-7015-11-78] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
10 Gowda CR, Lundt LP. Mechanism of action of narcolepsy medications. CNS Spectr 2014;19:25-34. [DOI: 10.1017/s1092852914000583] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
11 Cao M. Advances in narcolepsy. Med Clin North Am 2010;94:541-55. [PMID: 20451031 DOI: 10.1016/j.mcna.2010.02.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
12 Suzuki K, Miyamoto M, Miyamoto T, Inoue Y, Matsui K, Nishida S, Hayashida K, Usui A, Ueki Y, Nakamura M, Murata M, Numao A, Watanabe Y, Suzuki S, Hirata K. The Prevalence and Characteristics of Primary Headache and Dream-Enacting Behaviour in Japanese Patients with Narcolepsy or Idiopathic Hypersomnia: A Multi-Centre Cross-Sectional Study. PLoS One 2015;10:e0139229. [PMID: 26418536 DOI: 10.1371/journal.pone.0139229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
13 Persson PB. A tripling of readers: Acta Physiologica takes off. Acta Physiol (Oxf) 2012;205:189-90. [PMID: 22520691 DOI: 10.1111/j.1748-1716.2012.02440.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 McClung CA. How might circadian rhythms control mood? Let me count the ways... Biol Psychiatry 2013;74:242-9. [PMID: 23558300 DOI: 10.1016/j.biopsych.2013.02.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
16 de Almeida DE, Holoshitz J. MHC molecules in health and disease: At the cusp of a paradigm shift. Self Nonself 2011;2:43-8. [PMID: 21776334 DOI: 10.4161/self.2.1.15757] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
17 Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep 2017;9:39-57. [PMID: 28424564 DOI: 10.2147/NSS.S103467] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 9.4] [Reference Citation Analysis]
18 Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013;27:83-90. [PMID: 23359095 DOI: 10.1007/s40263-012-0036-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
19 Xiao F, Lu C, Zhao D, Zou Q, Xu L, Li J, Zhang J, Han F. Independent Component Analysis and Graph Theoretical Analysis in Patients with Narcolepsy. Neurosci Bull 2019;35:743-55. [PMID: 30421271 DOI: 10.1007/s12264-018-0307-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
20 van Drongelen V, Holoshitz J. Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis. Rheum Dis Clin North Am 2017;43:363-76. [PMID: 28711139 DOI: 10.1016/j.rdc.2017.04.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
21 Chrobok L, Palus-Chramiec K, Chrzanowska A, Kepczynski M, Lewandowski MH. Multiple excitatory actions of orexins upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal. Sci Rep 2017;7:7713. [PMID: 28794459 DOI: 10.1038/s41598-017-08202-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
22 Van Drongelen V, Holoshitz J. A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris. Front Biosci (Landmark Ed) 2017;22:909-19. [PMID: 27814654 DOI: 10.2741/4524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Seiden D, Tyler C, Dubow J. Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults. Clin Ther 2021;43:672.e1-672.e14. [PMID: 33632533 DOI: 10.1016/j.clinthera.2021.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns. Nat Sci Sleep 2020;12:453-66. [PMID: 32765142 DOI: 10.2147/NSS.S162762] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Micioni Di Bonaventura E, Botticelli L, Del Bello F, Giorgioni G, Piergentili A, Quaglia W, Cifani C, Micioni Di Bonaventura MV. Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior. Pharmacol Res 2021;172:105847. [PMID: 34438062 DOI: 10.1016/j.phrs.2021.105847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Arrambide G, Rovira A, Tur C, Montalban X. NMO spectrum disorders: how wide is the spectrum? Mult Scler 2014;20:1417-9. [DOI: 10.1177/1352458514546517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Correa-da-Silva F, Fliers E, Swaab DF, Yi CX. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome. J Neuroendocrinol 2021;33:e12994. [PMID: 34156126 DOI: 10.1111/jne.12994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Fulong X, Chao L, Dianjiang Z, Qihong Z, Wei Z, Jun Z, Fang H. Recursive Partitioning Analysis of Fractional Low-Frequency Fluctuations in Narcolepsy With Cataplexy. Front Neurol 2018;9:936. [PMID: 30450078 DOI: 10.3389/fneur.2018.00936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Girardin M, Ouellet SG, Gauvreau D, Moore JC, Hughes G, Devine PN, O’shea PD, Campeau L. Convergent Kilogram-Scale Synthesis of Dual Orexin Receptor Antagonist. Org Process Res Dev 2013;17:61-8. [DOI: 10.1021/op3002678] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
30 Swick TJ. Treatment paradigms for cataplexy in narcolepsy: past, present, and future. Nat Sci Sleep 2015;7:159-69. [PMID: 26715865 DOI: 10.2147/NSS.S92140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
31 Drissi NM, Szakács A, Witt ST, Wretman A, Ulander M, Ståhlbrandt H, Darin N, Hallböök T, Landtblom AM, Engström M. Altered Brain Microstate Dynamics in Adolescents with Narcolepsy. Front Hum Neurosci 2016;10:369. [PMID: 27536225 DOI: 10.3389/fnhum.2016.00369] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
32 Mosaad YM. Clinical Role of Human Leukocyte Antigen in Health and Disease. Scand J Immunol 2015;82:283-306. [PMID: 26099424 DOI: 10.1111/sji.12329] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
33 Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 11.4] [Reference Citation Analysis]